Finance

Lists
REVBW:NASDAQ
Revelation Biosciences
$0.0091
-3.19%
(-0.00030) 1D
Sep 11, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REVBW...
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
3.95M
Avg. vol.
2.18K
Volume
3.03K
52-wk high
$0.04
52-wk low
$0.00
Beta
3.51
No. of employees
8
Open
$0.01
High
$0.01
Low
$0.01
Mkt. cap
3.95M
Avg. vol.
2.18K
Volume
3.03K
52-wk high
$0.04
52-wk low
$0.00
Beta
3.51
No. of employees
8
About Revelation Biosciences
CEO-
Employees8
Founded2019
Headquarters-
SectorBiotechnology
Websiterevbiosciences.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
922.86K
964.19K
1.38M
1.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02M
1.61M
1.72M
1.74M
Operating expense
1.94M
2.57M
3.09M
3.66M
Total operating expenses
1.94M
2.57M
3.09M
3.66M
Operating income
-1.94M
-2.57M
-3.09M
-3.66M
Other non operating income
35.84K
60.58K
83.45K
338.86K
EBT including unusual items
-1.91M
-2.51M
-3.01M
-3.32M
EBT excluding unusual items
-1.91M
-2.51M
-3.01M
-3.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.91M
-2.51M
-3.01M
-3.32M
Net profit margin
-
-
-
-
Earnings per share
-7.08
-1.65
-2.71
-0.87
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.94M
-2.57M
-3.09M
-3.65M
Gain or loss from assets sale
4.49K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps